Nanobodies, also known as single-domain antibodies (sdAbs) or VHH antibodies, are only 1/10th the size of traditional monoclonal antibodies but can retain full antigen-binding potential, establishing ...

Current TCEs are based on antibodies and antibody fragments ... Poseidon can introduce multiple copies of the same nanobody to improve avidity, or utilize different nanobodies to increase specificity.

Their findings, including preclinical studies in mice, introduce the Adaptive Multi-Epitope Targeting and Avidity-Enhanced ...

Center have developed the first nanobody-based inhibitors targeting the Ebola virus. The research is published in the journal PLOS Pathogens. Nanobodies are tiny antibodies derived from animals ...